Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cvitkovic

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patientsA Yovine, M Riofrio, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignanciesE C Brain, A Mita, P Soulié, et al.
Journal of Mass Spectrometry : JMS|December 3, 1998
Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryH Rosing, M J Hillebrand, J M Jimeno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerJ L Misset, V Dieras, G Gruia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesotheliomaK Fizazi, R Caliandro, P Soulié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokineticsE Wasserman, C Cuvier, F Lokiec, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patientsJ P Droz, X Muracciole, N Mottet, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patientsA Yovine, M Riofrio, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignanciesE C Brain, A Mita, P Soulié, et al.
Journal of Mass Spectrometry : JMS|December 3, 1998
Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryH Rosing, M J Hillebrand, J M Jimeno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerJ L Misset, V Dieras, G Gruia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesotheliomaK Fizazi, R Caliandro, P Soulié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokineticsE Wasserman, C Cuvier, F Lokiec, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patientsJ P Droz, X Muracciole, N Mottet, et al.
Pageof 13